Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Assets (2016 - 2025)

China Pharma Holdings' Return on Assets history spans 15 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Assets rose 20.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, up 20.0%, while the annual FY2025 figure was 0.14%, 16.0% up from the prior year.
  • Return on Assets reached 0.14% in Q4 2025 per CPHI's latest filing, up from 0.22% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.14% in Q4 2025 to a low of 0.34% in Q3 2024.
  • Average Return on Assets over 5 years is 0.22%, with a median of 0.2% recorded in 2023.
  • Peak YoY movement for Return on Assets: surged 79bps in 2021, then fell -14bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.17% in 2021, then tumbled by -40bps to 0.23% in 2022, then increased by 17bps to 0.19% in 2023, then crashed by -73bps to 0.33% in 2024, then skyrocketed by 59bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Return on Assets are 0.14% (Q4 2025), 0.22% (Q3 2025), and 0.26% (Q2 2025).